Biohit Oyj Valuation
| BIOBV Stock | EUR 2.33 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Biohit Oyj B shows a prevailing Real Value of €1.97 per share. The current price of the firm is €2.33. Our model approximates the value of Biohit Oyj B from analyzing the firm fundamentals such as Return On Equity of 0.0645, profit margin of 0.04 %, and Current Valuation of 20.88 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biohit Oyj's price fluctuation is unstable at this time. Calculation of the real value of Biohit Oyj B is based on 3 months time horizon. Increasing Biohit Oyj's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Biohit Oyj is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biohit Stock. However, Biohit Oyj's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.33 | Real 1.97 | Hype 2.33 |
The intrinsic value of Biohit Oyj's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Biohit Oyj's stock price.
Estimating the potential upside or downside of Biohit Oyj B helps investors to forecast how Biohit stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biohit Oyj more accurately as focusing exclusively on Biohit Oyj's fundamentals will not take into account other important factors: Biohit Oyj Total Value Analysis
Biohit Oyj B is currently forecasted to have takeover price of 20.88 M with market capitalization of 30.69 M, debt of 59 K, and cash on hands of 9.38 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biohit Oyj fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
20.88 M | 30.69 M | 59 K | 9.38 M |
Biohit Oyj Investor Information
About 47.0% of the company shares are held by company insiders. The book value of Biohit Oyj was currently reported as 0.53. The company last dividend was issued on the 15th of April 2014. Biohit Oyj B is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Biohit Oyj Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biohit Oyj has an asset utilization ratio of 97.38 percent. This signifies that the Company is making €0.97 for each dollar of assets. An increasing asset utilization means that Biohit Oyj B is more efficient with each dollar of assets it utilizes for everyday operations.Biohit Oyj Ownership Allocation
The market capitalization of Biohit Oyj B is €30.69 Million. Biohit Oyj B retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Biohit Oyj Profitability Analysis
The company reported the revenue of 9.36 M. Net Loss for the year was (1.5 M) with profit before overhead, payroll, taxes, and interest of 5.92 M.About Biohit Oyj Valuation
An absolute valuation paradigm, as applied to Biohit Stock, attempts to find the value of Biohit Oyj B based on its fundamental and basic technical indicators. By analyzing Biohit Oyj's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Biohit Oyj's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biohit Oyj. We calculate exposure to Biohit Oyj's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biohit Oyj's related companies.Biohit Oyj, a biotechnology company, produces diagnostic tests and analysis systems for use in research institutions and healthcare industries worldwide. The company was founded in 1988 and is headquartered in Helsinki, Finland. Biohit Oyj operates under Healthcare Services classification in Finland and is traded on Helsinki Exchange. It employs 49 people.
8 Steps to conduct Biohit Oyj's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biohit Oyj's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biohit Oyj's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Biohit Oyj's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Biohit Oyj's revenue streams: Identify Biohit Oyj's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Biohit Oyj's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Biohit Oyj's growth potential: Evaluate Biohit Oyj's management, business model, and growth potential.
- Determine Biohit Oyj's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biohit Oyj's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Biohit Stock analysis
When running Biohit Oyj's price analysis, check to measure Biohit Oyj's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohit Oyj is operating at the current time. Most of Biohit Oyj's value examination focuses on studying past and present price action to predict the probability of Biohit Oyj's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohit Oyj's price. Additionally, you may evaluate how the addition of Biohit Oyj to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |